Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET
Company Participants
Neda Safarzadeh – Vice President, Head of Investor Relations, Public Relations and Marketing
Joe Payne – President and Chief Executive Officer
Andy Sassine – Chief Financial Officer
Pad Chivukula – Chief Scientific Officer and Chief Operating Officer
Conference Call Participants
Lili Nsongo – Leerink Partners
Yasmeen Rahimi – Piper Sandler
Evan Wang – Guggenheim Securities
Jake Roberge – William Blair
Whitney Ijem – Canaccord Genuity
Samantha Schaeffer – Cantor Fitzgerald
Tom Shrader – BTIG
Yigal Nochomovitz – Citi
Yanan Zhu – Wells Fargo
Yale Jen – Laidlaw & Company
Operator
Good day. I would like to welcome everyone to Arcturus Therapeutics’ First Quarter 2025 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions] Today’s call is being recorded.
I would now like to turn the call over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations, and Marketing. Please go ahead.
Neda Safarzadeh
Thank you, Operator. Good afternoon, and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. Today’s call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO. Dr. Pad Chivukula, our CSO and COO, will join them for the Q&A session.
Before we begin, I would like to remind everyone that the statements made during this call regarding matters that are not historical facts are forward-looking statements within the Safe Harbor provisions of the Private Securities Legation Reform Act of 1995. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties, and assumptions that may cause actual results, performance, and achievements to differ materially from those expressed or implied by this statement.
#Arcturus #Therapeutics #Holdings #ARCT #Earnings #Call #Transcript